Renal Cancer - Results from #3980

miR‑122 promotes proliferation and invasion of clear cell renal cell carcinoma by suppressing Forkhead box O3. December 4, 2018

IKBKB expression in clear cell renal cell carcinoma is associated with tumor grade and patient outcomes. December 4, 2018

Everolimus versus Sunitinib for Patients with Metastatic Non-clear Cell Renal Cell Carcinoma (ASPEN): a Multicentre, Open-label, Randomised Phase 2 Trial December 3, 2018

Cabozantinib versus Everolimus in Advanced Renal Cell Carcinoma (METEOR): Final Results from a Randomised, Open-label, Phase 3 Trial December 3, 2018

Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma December 3, 2018

Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial December 3, 2018

PRINCIPAL: A Prospective Observational Study of Real-world Treatment Patterns and Treatment Outcomes in Patients with Advanced or Metastatic Renal Cell Carcinoma (mRCC) Receiving Pazopanib. December 3, 2018

Giant bilateral renal metastases from a meningeal hemangiopericytoma. December 3, 2018

CircPCNXL2 sponges miR-153 to promote the proliferation and invasion of renal cancer cells through upregulating ZEB2. December 3, 2018

Clinical significance of glutamate metabotropic receptors in renal cell carcinoma risk and survival. December 3, 2018

Mitochondrial PIWI-interacting RNAs are novel biomarkers for clear cell renal cell carcinoma. December 3, 2018

Mutations in renal cell carcinoma. November 30, 2018

Age-related variations in gene expression patterns of renal cell carcinoma. November 30, 2018

Predicting Renal Function Outcomes After Partial and Radical Nephrectomy. November 30, 2018

The Molecular Characterization and Therapeutic Strategies of Papillary renal cell carcinoma. November 30, 2018

Emerging Role of Combination Immunotherapy in the First-line Treatment of Advanced Renal Cell Carcinoma: A Review. November 29, 2018

Comparison of axitinib and sunitinib as first-line therapies for metastatic renal cell carcinoma: a real-world multicenter analysis. November 29, 2018

The side and the location of the primary tumor does not affect the probability of lymph node invasion in patients with renal cell carcinoma. November 29, 2018

Assessment of volume preservation performed before or after partial nephrectomy accurately predicts postoperative renal function: Results from a prospective multicenter study. November 29, 2018

Tyrosine Kinase Inhibitor Pazopanib Inhibits Platelet Procoagulant Activity in Renal Cell Carcinoma Patients. November 28, 2018

Page 200 of 456